Managing Partner, Bridge Valley Ventures
Allan Marchington is a founder and Managing Partner at Bridge Valley Ventures a UK based Life Science investor which was established by LifeArc of the UK leading medical charities. Prior to BVV, Allan was formerly a Founding Partner at Apposite Capital and an EIR at Abingworth management. Before Abingworth Allan has a number of operational roles; as Senior Vice President at Millennium Pharmaceuticals where he served on the senior management team in Cambridge Mass. He also served as Chairman of Millennium Pharmaceuticals in Europe. Allan joined Millennium following their acquisition in July 2000 of UK based company Cambridge Discovery Chemistry, where he was CEO and founder. Allan began his career as a medicinal chemist at Pfizer Central Research.
Allan has served on a number successful company Boards including the UK BioIndustry Association, Ambit Biosciences Inc., Ambrx Inc., Birdrock Bio Inc., Calchan Ltd and Convergence Pharmaceuticals Ltd.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557